GFAP and myeloid sarcoma: Additionally, markers for neuronal damage and glial activation, such as neurofilaments (NF) and glial fibrillary acidic protein (GFAP) [19], correlate with disease severity, activity, and duration [20] and have prognostic value [21], making them potential biomarkers in MS.